Prosecution Insights
Last updated: October 04, 2026

Lucase3 L C

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Lucase3 L C currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are both contained within 1 distinct art unit. This structure suggests that the company's pending technology is concentrated in 1 administrative department, even though multiple examiners are reviewing the work.

The busiest examiner for the portfolio is MILLER-CRUZ, EKANDRA S., who is handling 1 busiest examiner pending action. This is 1 of the 2 pending office actions for the company. The presence of 2 distinct examiners requires the company to manage 2 different sets of feedback and procedural expectations within the same 1 distinct art unit.

The focus on Biotechnology & Pharmaceuticals indicates a specialized patenting effort. With 2 pending office actions total, the company's prosecution pipeline is currently small. However, the use of 2 distinct examiners within 1 distinct art unit means that the company must be prepared for potentially different interpretations of the same technical field or prior art.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
§112 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MILLER-CRUZ, EKANDRA S. 1 65.8% +51.9%
MONSHIPOURI, MARYAM 1 79.1% +37.5%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18734118 SYSTEM AND METHOD FOR STARTCH SEPARATION AND DRY FRACTURING WITH FIBER WASH MILLER-CRUZ, EKANDRA S. —
18223346 HIGH VALUE PROTEIN PRODUCTION FROM WASTE ORGANIC STREAMS AT AN EXISTING ETHANOL PLANT MONSHIPOURI, MARYAM —

Top Art Units

Art UnitApps
1651 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18734118 SYSTEM AND METHOD FOR STARTCH SEPARATION AND DRY FRACTURING WITH FIBER WASH MILLER-CRUZ, EKANDRA S. — §103Other Non-Final OA — Pending Jun 05, 2024
18223346 HIGH VALUE PROTEIN PRODUCTION FROM WASTE ORGANIC STREAMS AT AN EXISTING ETHANOL PLANT MONSHIPOURI, MARYAM 1651 §112 Final Rejection — Pending Jul 18, 2023

Managing Lucase3 L C's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month